Skip to main content

Smokers

1
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Sandoz
SandozAustria - Kundl
1 program
1
NIC002Phase 2
MTI
MTIUT - Salt Lake City
1 program
Isometric trunk exercisesN/A1 trial
Active Trials
NCT07241624Completed90Est. Jan 2026
Novartis
NovartisBASEL, Switzerland
1 program
NIC002PHASE_22 trials
Active Trials
NCT01280968Completed52Est. Apr 2013
NCT00736047Completed200Est. Oct 2009
Pierre Fabre
Pierre FabreFrance - Aignan
1 program
V0116 transdermal patchPHASE_21 trial
Active Trials
NCT01655082Completed160Est. Oct 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Pierre FabreV0116 transdermal patch
NovartisNIC002
NovartisNIC002
MTIIsometric trunk exercises

Clinical Trials (4)

Total enrollment: 502 patients across 4 trials

NCT01655082Pierre FabreV0116 transdermal patch

Nicotine Patch Safety Study

Start: Aug 2012Est. completion: Oct 2012160 patients
Phase 2Completed
NCT01280968NovartisNIC002

Improving the Efficacy of Anti-Nicotine Immunotherapy

Start: Dec 2010Est. completion: Apr 201352 patients
Phase 2Completed
NCT00736047NovartisNIC002

Study to Evaluate the Efficacy, Safety, Tolerability and Immunogenicity of 100µg NIC002 Vaccine in Cigarette Smokers Who Are Motivated to Quit Smoking.

Start: Aug 2008Est. completion: Oct 2009200 patients
Phase 2Completed
NCT07241624MTIIsometric trunk exercises

Isometric Versus Isotonic Trunk Muscle Strength Training on Lung Function in Heavy Smokers

Start: Oct 2025Est. completion: Jan 202690 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.